BIOTRICITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
BIOTRICITY INC. (BTCY) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $1.20 per share as of 2024-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2025-11-14
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.20.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.48.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.78.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.79.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price as first filed |
|---|---|---|
| 2024-09-30 | $1.20 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.48 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $2.78 10-K/A · filed 2025-07-18 | |
| 2023-12-31 | $2.79 10-Q/A · filed 2025-02-20 | |
| 2023-09-30 | $2.79 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.47 10-Q · filed 2024-08-19 | |
| 2022-12-31 | $4.80 10-Q · filed 2024-02-20 | |
| 2022-09-30 | $4.80 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.77 10-Q · filed 2023-08-14 | |
| 2019-03-31 | $0.58 10-Q · filed 2019-11-14 | $2.00 10-Q · filed 2019-08-15 |
| 2016-03-31 | $0.00 10-Q · filed 2020-02-14 |